Identification of a new tamoxifen-xanthene hybrid as pro-apoptotic anticancer agent
Elena Catanzaro1, Francesca Seghetti2, Cinzia Calcabrini1
1Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.
Abstract:
Breast cancer is the most diagnosed type of cancer among women for which an exhaustive cure has not been discovered yet. Nowadays, tamoxifen still represents the gold standard for breast cancer therapy; it acts on both estrogen receptor-positive and estrogen receptor-negative breast cancers. Unfortunately, its toxicity and the related chemoresistance undermine its antitumor potential. In this paper, new tamoxifen-based derivatives with a rigid structural motif in their structure were designed, synthesized, and evaluated to assess their antitumor behavior. All the tested compounds affected estrogen receptor-positive tumor (MCF-7) cell growth, even with different extents, among which, the most active ones proved also to induce mitochondria-mediated apoptosis through activation of PARP cleavage, decrease in Bax/Bcl-2 ratio and increase in Bim gene expression levels. Here we found that the compound 1, carrying a rigid xanthene core, turned out to be the most promising of the set showing an activity profile comparable to that of tamoxifen. Furthermore, a more favorable genotoxic profile than tamoxifen made compound 1 a promising candidate for further studies.
Insights
New tamoxifen derivatives were synthesized to improve breast cancer treatment. Compound 1, featuring a rigid xanthene core, shows potent antitumor activity and a better safety profile than tamoxifen.
Area of Science:
- Medicinal Chemistry
- Oncology
- Molecular Biology
Background:
- Breast cancer is a leading cancer in women, with tamoxifen as a standard therapy.
- Tamoxifen's efficacy is limited by toxicity and chemoresistance.
- Novel therapeutic strategies are needed to overcome tamoxifen's limitations.
Purpose of the Study:
- To design and synthesize novel tamoxifen-based derivatives with rigid structures.
- To evaluate the antitumor potential of these new compounds.
- To identify promising candidates for further breast cancer drug development.
Main Methods:
- Synthesis of new tamoxifen derivatives incorporating rigid structural motifs.
- In vitro evaluation of antiproliferative activity against estrogen receptor-positive breast cancer cells (MCF-7).
- Assessment of apoptosis induction mechanisms, including PARP cleavage, Bax/Bcl-2 ratio, and Bim gene expression.
Main Results:
- All tested compounds inhibited MCF-7 cell growth.
- Compound 1, with a xanthene core, exhibited significant antitumor activity comparable to tamoxifen.
- Compound 1 demonstrated mitochondria-mediated apoptosis induction.
- Compound 1 showed a more favorable genotoxic profile than tamoxifen.
Conclusions:
- Tamoxifen-based derivatives with rigid structures can be effective against breast cancer.
- Compound 1 is a highly promising candidate due to its potent activity and improved safety profile.
- Further studies are warranted to explore Compound 1's therapeutic potential in breast cancer.
Related Concept Videos
Hybrid Zones
Hybridization of Atomic Orbitals I
Hybridization of Atomic Orbitals II
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...


